ERBB2 and breast cancer: Several BC therapies may indeed cause CV adverse effects, in the short and long-term, and in particular left ventricular dysfunction (LVD) due to anthracyclines and drugs targeting the human epidermal growth factor receptor 2 (HER2) (6, 7).